Previous 10 | Next 10 |
MENLO PARK, Calif., June 17, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced the publication of “AGE LATER: Health Span, Life...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
MENLO PARK, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, is hosting its Annual Shareholder Meeting and Investor Update on June 16...
MENLO PARK, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced its Chief Executive Officer, Steven Engle will be a part...
The following slide deck was published by CohBar, Inc. in conjunction with their 2020 Q1 earnings Read more ...
CohBar, Inc. (CWBR) Q1 2020 Earnings Conference Call May 14, 2020 5:00 PM ET Company Participants Jordyn Tarazi - Director of Investor Relations Steve Engle - Chief Executive Officer Jeff Biunno - Chief Financial Officer Ken Cundy - Chief Scientific Officer Conference Call P...
MENLO PARK, Calif., May 14, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today reported its financial results for the first quarter ended March 3...
CohBar (NASDAQ: CWBR ) COO Jon Stern plans to step down, effective May 31, 2020. Mr. Stern had joined the company in 2012. More news on: CohBar, Inc., Healthcare stocks news, Stocks on the move, Read more ...
MENLO PARK, Calif., May 13, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced that Jon Stern plans to step down from his role as the c...
CohBar ( CWBR ) is a company working to combat the diseases of aging that has tremendous upside potential. This is because the markets they are targeting-NASH, obesity, type 2 diabetes, fibrotic diseases, and cancer-are all huge, yet the company's market cap is under $150 million. CohBar is se...
News, Short Squeeze, Breakout and More Instantly...
3D Systems Corporation (DDD) is expected to report $-0.11 for Q1 2024 ZW Data Action Technologies Inc. (CNET) is expected to report for Q1 2024 Celularity Inc. (CELU) is expected to report for Q1 2023 DMK Pharmaceuticals Corporation (DMKPQ) is expected to report for Q1 2024 Atlant...
ADDvantage Technologies Group Inc. (AEYGQ) is expected to report for Q1 2024 ContraFect Corporation (CFRXQ) is expected to report for Q1 2024 American Clean Resources Group Inc (ACRG) is expected to report for Q1 2024 Atlantic Lithium Ltd Ord Fully Paid (ALLIF) is expected to report f...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...